Mount Laurel, NJ, United States of America

Maria Betty

This inventor holds 7 USPTO granted patents. Top assignees: Millennium Pharmaceuticals Limited, Wyeth, Other. Active years: 2002-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Betty. Retrieved from https://idiyas.com/inventor/maria-betty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 85.7

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Moorestown, NJ (US) (2002 - 2006)
  • Mt. Laurel, NJ (US) (2002 - 2009)

Company Filing History:

goldMedal4 out of 854 
 
Millennium Pharmaceuticals Limited
 patents
silverMedal4 out of 1,309 
 
Wyeth
 patents
bronzeMedal3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2009

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Maria Betty: Innovator in Potassium Channel Research

Introduction

Maria Betty is a prominent inventor based in Mt. Laurel, NJ (US). She has made significant contributions to the field of molecular biology, particularly in the study of potassium channels. With a total of 7 patents to her name, her work has advanced our understanding of how these channels function and their implications in various biological processes.

Latest Patents

Among her latest patents, Maria has developed innovative technologies related to nucleic acids encoding potassium channel interactors. This invention provides isolated nucleic acid molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel-mediated activities. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. Additionally, the invention provides isolated PCIP proteins, fusion proteins, antigenic peptides, and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also included.

Another significant patent is related to human 9q polypeptides, which also involves isolated nucleic acids that encode proteins interacting with potassium channels. This patent shares similarities with her previous work, emphasizing the importance of PCIP nucleic acids in modulating potassium channel activities.

Career Highlights

Maria has worked with notable companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Wyeth. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Throughout her career, Maria has collaborated with esteemed colleagues such as Kenneth Rhodes and Huai-Ping Ling. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Maria Betty is a trailblazer in the field of potassium channel research, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to influence the scientific community and pave the way for future advancements in molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…